Abiraterone Acetate Tablet
Product Images NDC 60219-1165
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 60219-1165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
2 (Abiraterone Acetate Tablets Usp 250 mg 500 mg 2)
3 (Abiraterone Acetate Tablets Usp 250 mg 500 mg 3)
This appears to be data related to a clinical trial, where the subjects were grouped into two groups - Acetate and Placebo. The horizontal axis shows the number of months from randomization while the vertical axis shows the number of subjects without death. The numbers seem to represent the count of subjects at each time point for each group. The last line seems to suggest a comparison between the Placebo and Abiraterone Acetate groups.*
4 (Abiraterone Acetate Tablets Usp 250 mg 500 mg 4)
5 (Abiraterone Acetate Tablets Usp 250 mg 500 mg 5)
1 (Abiraterone Acetate Tablets Usp 250 mg 500 mg 6)
Abiraterone Acetate is a prescription drug available in tablet form, with NDC number 60219-1165-7. The drug must be handled with gloves by women who are pregnant or may become pregnant. The tablets should not be chewed or crushed and should be stored at room temperature between 15°C to 30°C. Each tablet contains Abiraterone Acetate, USP and is meant to be swallowed whole. The package insert should be consulted for usual dosage. The drug is manufactured by Amneal Pharmaceuticals Private Limited in India and distributed by Amneal Pharmaceuticals LG in Bridgewater, NJ.*
1 (Abiraterone Acetate Tablets Usp 250 mg 500 mg 7)
Abiraterone Acetate Tablets are used for treating prostate cancer. Each tablet contains 500 mg of Abiraterone Acetate. Follow the instructions listed on the package insert to determine the correct dosage. It is recommended to swallow the whole tablet and avoid crushing it. Store the tablets between 20°C to 25°C and keep them out of the reach of children. The tablets are manufactured by Amneal Pharmaceuticals Private Limited in Ahmadabad, India, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The manufacturing license number is 6/25/1941, and the revision number is 02-2023-01.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.